Abstract Details
|
Emer McGrath, MB, BCh, PhD
PRESENTER |
Dr. McGrath has nothing to disclose. |
| Alexa Beiser | Alexa Beiser has nothing to disclose. |
| Charles S. DeCarli, MD, FÂ鶹´«Ã½Ó³» (UC Davis Health - Dept of NeurologyAlzheimer's Disease Research Center) | Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH. |
| No disclosure on file | |
| No disclosure on file | |
| Steven M. Greenberg, MD, PhD, FÂ鶹´«Ã½Ó³» | Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. The institution of Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Greenberg has received research support from National Institutes of Health. Dr. Greenberg has received publishing royalties from a publication relating to health care. |
| Sudha Seshadri, MD, FÂ鶹´«Ã½Ó³» (Glenn Biggs Institute for Alzheimer'S and Neurodegenerative Diseases) | Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association. |